Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany
- PMID: 22960495
- PMCID: PMC3660760
- DOI: 10.4161/hv.21593
Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany
Abstract
In Germany, routine RV-vaccination is not adopted into the national immunization schedule as of 2012. Because RV-vaccines were already on the market since 2006, in 2010 a moderate (58%) and low (22%) vaccine uptake was observed in the 5 eastern federal states (EFS) and the 11 western federal states (WFS), respectively. To assess the impact of RV-vaccination, we compared the incidence rates (IR) of RV-related hospitalizations before (2004‒2006) and in seasons after (2008/09-2010/11) RV-vaccine introduction in Germany by utilizing data from the national mandatory disease reporting system. In the EFS, the IR was significantly reduced in age-groups < 18 mo in 2008/09 and in age-groups < 24 mo in 2009/10-2010/11. In the WFS an IR-reduction was observed only in age-groups < 12 mo in 2008/09 and in age-groups < 18 mo in 2009/10-2010/11. Overall IR-reduction in age-groups < 24 mo comparing 2008-11 with 2004-06 was 36% and 25% in EFS and WFS, respectively. In addition, we computed IR-ratios (IRR) in the seasons after mid-2006 with negative binomial regression. The effect of vaccination was independent from the geographic region. Vaccination was associated with a significant reduction in RV-related hospitalizations in the age-groups 6-23 mo. Most prominently, vaccination of 50% of infants led to an estimated decrease in age group 6-11 mo by 42%. No significant reduction was observed in age-groups ≥ 24 mo. In conclusion, in the German setting with low to moderate vaccine uptake, RV-related hospitalization incidence decreased substantially depending on the achieved vaccination coverage, but only in the first two years of life.
Keywords: Germany; hospitalization; impact; incidence; nosocomial; rotavirus; vaccination.
Figures
Similar articles
-
Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.Vaccine. 2014 Sep 8;32(40):5250-7. doi: 10.1016/j.vaccine.2014.06.090. Epub 2014 Jul 18. Vaccine. 2014. PMID: 25045820
-
Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction.Pediatr Infect Dis J. 2020 Jul;39(7):e109-e116. doi: 10.1097/INF.0000000000002656. Pediatr Infect Dis J. 2020. PMID: 32187139
-
Background paper to the recommendation for routine rotavirus vaccination of infants in Germany.Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jul;56(7):957-84. doi: 10.1007/s00103-013-1777-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013. PMID: 23807405
-
Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned.Expert Rev Vaccines. 2020 Aug;19(8):755-769. doi: 10.1080/14760584.2020.1800459. Epub 2020 Sep 4. Expert Rev Vaccines. 2020. PMID: 32729747 Review.
-
Rotavirus vaccination in Japan: Efficacy and safety of vaccines, changes in genotype, and surveillance efforts.J Infect Chemother. 2021 Jul;27(7):940-948. doi: 10.1016/j.jiac.2021.04.002. Epub 2021 Apr 15. J Infect Chemother. 2021. PMID: 33867267 Review.
Cited by
-
Letter to the editor in response to: Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence.Hum Vaccin Immunother. 2021 Oct 3;17(10):3638-3640. doi: 10.1080/21645515.2021.1929791. Epub 2021 Jun 25. Hum Vaccin Immunother. 2021. PMID: 34170202 Free PMC article. No abstract available.
-
Recommendation of rotavirus vaccination and herd effect: a budget impact analysis based on German health insurance data.Eur J Health Econ. 2015 Sep;16(7):719-31. doi: 10.1007/s10198-014-0624-2. Epub 2014 Aug 19. Eur J Health Econ. 2015. PMID: 25135769 Free PMC article.
-
Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.Hum Vaccin Immunother. 2022 Dec 31;18(1):1870395. doi: 10.1080/21645515.2020.1870395. Epub 2021 Feb 19. Hum Vaccin Immunother. 2022. PMID: 33605839 Free PMC article. Review.
-
Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain.Hum Vaccin Immunother. 2015;11(3):769-75. doi: 10.1080/21645515.2015.1009339. Hum Vaccin Immunother. 2015. PMID: 25644531 Free PMC article.
-
Burden of acute gastroenteritis, norovirus and rotavirus in a managed care population.Hum Vaccin Immunother. 2014;10(6):1544-56. doi: 10.4161/hv.28704. Epub 2014 Apr 14. Hum Vaccin Immunother. 2014. PMID: 24732307 Free PMC article.
References
-
- Robert Koch -Institut. Infektionsepidemiologisches Jahrbuch für 2010, Berlin, 2011.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical